PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages
dc.contributor.author | Pitter, MR | |
dc.contributor.author | Kryczek, I | |
dc.contributor.author | Zhang, H | |
dc.contributor.author | Nagarsheth, N | |
dc.contributor.author | Xia, H | |
dc.contributor.author | Wu, Z | |
dc.contributor.author | Tian, Y | |
dc.contributor.author | Okla, K | |
dc.contributor.author | Liao, P | |
dc.contributor.author | Wang, W | |
dc.contributor.author | Zhou, J | |
dc.contributor.author | Li, G | |
dc.contributor.author | Lin, H | |
dc.contributor.author | Vatan, L | |
dc.contributor.author | Grove, S | |
dc.contributor.author | Wei, S | |
dc.contributor.author | Li, Y | |
dc.contributor.author | Zou, W | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-06-06T20:37:51Z | |
dc.date.available | 2024-06-06T20:37:51Z | |
dc.date.issued | 2024-03-26 | |
dc.identifier.issn | 2211-1247 | |
dc.identifier.issn | 2211-1247 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/38489266 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/193534 | en |
dc.description.abstract | Tumor-associated macrophages (TAMs) shape tumor immunity and therapeutic efficacy. However, it is poorly understood whether and how post-translational modifications (PTMs) intrinsically affect the phenotype and function of TAMs. Here, we reveal that peptidylarginine deiminase 4 (PAD4) exhibits the highest expression among common PTM enzymes in TAMs and negatively correlates with the clinical response to immune checkpoint blockade. Genetic and pharmacological inhibition of PAD4 in macrophages prevents tumor progression in tumor-bearing mouse models, accompanied by an increase in macrophage major histocompatibility complex (MHC) class II expression and T cell effector function. Mechanistically, PAD4 citrullinates STAT1 at arginine 121, thereby promoting the interaction between STAT1 and protein inhibitor of activated STAT1 (PIAS1), and the loss of PAD4 abolishes this interaction, ablating the inhibitory role of PIAS1 in the expression of MHC class II machinery in macrophages and enhancing T cell activation. Thus, the PAD4-STAT1-PIAS1 axis is an immune restriction mechanism in macrophages and may serve as a cancer immunotherapy target. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation.haspart | 113942 | |
dc.rights | Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | CP: Cancer | |
dc.subject | CP: Immunology | |
dc.subject | MHC | |
dc.subject | PAD4 | |
dc.subject | PIAS | |
dc.subject | STAT1 | |
dc.subject | T cell | |
dc.subject | antigen presentation | |
dc.subject | checkpoint | |
dc.subject | citrullination | |
dc.subject | immunotherapy | |
dc.subject | macrophage | |
dc.subject | tumor | |
dc.subject | Mice | |
dc.subject | Animals | |
dc.subject | Protein-Arginine Deiminases | |
dc.subject | Protein-Arginine Deiminase Type 4 | |
dc.subject | Hydrolases | |
dc.subject | Protein Processing, Post-Translational | |
dc.subject | Histocompatibility Antigens Class II | |
dc.subject | Macrophages | |
dc.title | PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages | |
dc.type | Article | |
dc.identifier.pmid | 38489266 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/193534/2/PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.pdf | |
dc.identifier.doi | 10.1016/j.celrep.2024.113942 | |
dc.identifier.doi | https://dx.doi.org/10.7302/23176 | |
dc.identifier.source | Cell Reports | |
dc.description.version | Published version | |
dc.date.updated | 2024-06-06T20:37:48Z | |
dc.identifier.orcid | 0000-0002-3130-2533 | |
dc.identifier.orcid | 0000-0002-8409-5574 | |
dc.identifier.orcid | 0000-0002-2703-5268 | |
dc.identifier.orcid | 0000-0001-7952-3549 | |
dc.identifier.volume | 43 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 113942 | |
dc.identifier.name-orcid | Pitter, MR | |
dc.identifier.name-orcid | Kryczek, I; 0000-0002-3130-2533 | |
dc.identifier.name-orcid | Zhang, H | |
dc.identifier.name-orcid | Nagarsheth, N | |
dc.identifier.name-orcid | Xia, H | |
dc.identifier.name-orcid | Wu, Z | |
dc.identifier.name-orcid | Tian, Y | |
dc.identifier.name-orcid | Okla, K | |
dc.identifier.name-orcid | Liao, P; 0000-0002-8409-5574 | |
dc.identifier.name-orcid | Wang, W | |
dc.identifier.name-orcid | Zhou, J | |
dc.identifier.name-orcid | Li, G | |
dc.identifier.name-orcid | Lin, H | |
dc.identifier.name-orcid | Vatan, L | |
dc.identifier.name-orcid | Grove, S | |
dc.identifier.name-orcid | Wei, S; 0000-0002-2703-5268 | |
dc.identifier.name-orcid | Li, Y | |
dc.identifier.name-orcid | Zou, W; 0000-0001-7952-3549 | |
dc.working.doi | 10.7302/23176 | en |
dc.owningcollname | Surgery, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.